COVID-19 Vaccines and Effective Communications Strategies

The U.S. distribution of safe and efficacious vaccines to prevent COVID-19 has increased exponentially since December 2020. The average daily rates of vaccines administered in the U.S. has reached 3.3 million in April. On April 14, the U.S. reached more than 194.8 million total doses administered with 76.7 million persons (23.1% of the total U.S….

Read More →

Bipartisan Coalition of Attorneys General Fight Unlawful Sales of Fake COVID-19 Vaccination Cards

Washington, D.C. — The National Association of Attorneys General (NAAG) today called on Twitter, eBay, and Shopify to act immediately to prevent people from selling fraudulent CDC vaccination cards on their platforms. The bipartisan coalition, led by North Carolina Attorney General Josh Stein and Tennessee Attorney General Herbert H. Slatery III, raised concerns about the…

Read More →

NAAG Works to Prevent the Online Sale of Fraudulent COVID Vaccination Cards

The false and deceptive marketing and sales of fake COVID vaccine cards threaten the health of our communities, slow progress in getting our residents protected from the virus, and are a violation of the laws of many states.

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: March 2021 Update for the Attorney General Community

The distribution of three safe and efficacious vaccines to prevent COVID-19 has continued to ramp up both globally and domestically. Here in the U.S., average daily rates of vaccines administered has increased from 1.5 million at the end of February to close to 2.5 million in March. On March 24, the U.S. reached over 130…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: February 2021 Update for the Attorney General Community

In December 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech and Moderna vaccines to prevent COVID-19. Within twenty-four hours of each authorization, doses began shipping across the country to every state, marking significant milestones in the national response to the COVID-19 pandemic. Since then, over sixty-six million…

Read More →

NAGTRI Resources and Training on the Legal and Policy Implications for COVID-19 Vaccines

On December 11, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech vaccine to prevent COVID-19 among individuals 16 years of age and older. The following week, the FDA granted a separate EUA for the Moderna COVID-19 vaccine for those 18 years and older.  Within twenty-four hours…

Read More →

Congress Passes “No Surprises Act” To Protect Consumers From Unexpected Medical Bills

Tucked inside the omnibus appropriations bill that was passed in the waning days of the 116th Congress, the “No Surprises Act” aims to address the problem of surprise medical bills. Surprise medical bills happen when a patient unexpectedly receives services from an out-of-network provider or in an out-of-network facility. The bill provides protection from surprise medical…

Read More →

National Legal and Policy Implications for COVID-19 Vaccines Training

This intensive, online training allows participants to explore the legal implications that may arise following the Food & Drug Administration (FDA) approval or authorization of one or more COVID-19 vaccine. The training will include topical presentations and discussion of various potential vaccine-related legal and policy issues. Faculty-led presentations will cover: COVID-19 legal issues and the…

Read More →

States’ Tobacco Master Settlement Agreement Helps Implement CDC Strategies to Reduce Tobacco Use

The Centers for Disease Control recently published results from its 2020 National Health Interview Survey on the subject of “Tobacco Product Use Among Adults – United States, 2019.”1 The CDC summarized the survey’s findings as follows: “In 2019, approximately 20.8% of U.S. adults (50.6 million) currently used any tobacco product. Cigarettes were the most commonly…

Read More →

NAAG Asks FDA for Progress Update Under the SUPPORT Act

We have witnessed first-hand the devastation that the opioid epidemic has wrought on states in terms of lives lost and the costs it has imposed on our healthcare system and the broader economy.

Read More →